N-[5-bromo-3-fluoro-2-[(3S,5S)-3,4,5-trimethylpiperazin-1-yl]phenyl]-4-fluoro-2-(trifluoromethyl)benzamide
C21H21BrF5N3O — CID 156905317
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-bromo-3-fluoro-2-[(3S,5S)-3,4,5-trimethylpiperazin-1-yl]phenyl]-4-fluoro-2-(trifluoromethyl)benzamide
N-[5-bromo-3-fluoro-2-[(3S,5S)-3,4,5-trimethylpiperazin-1-yl]phenyl]-4-fluoro-2-(trifluoromethyl)benzamide (PubChem CID 156905317) has the molecular formula C21H21BrF5N3O and a molecular weight of 506.31 g/mol. Its IUPAC name is N-[5-bromo-3-fluoro-2-[(3S,5S)-3,4,5-trimethylpiperazin-1-yl]phenyl]-4-fluoro-2-(trifluoromethyl)benzamide.
Molecular Properties
| Compound Name | N-[5-bromo-3-fluoro-2-[(3S,5S)-3,4,5-trimethylpiperazin-1-yl]phenyl]-4-fluoro-2-(trifluoromethyl)benzamide |
|---|---|
| PubChem CID | 156905317 |
| Molecular Formula | C21H21BrF5N3O |
| Molecular Weight | 506.31 g/mol |
| Exact Mass | 505.08 |
| IUPAC Name | N-[5-bromo-3-fluoro-2-[(3S,5S)-3,4,5-trimethylpiperazin-1-yl]phenyl]-4-fluoro-2-(trifluoromethyl)benzamide |
| SMILES | C[C@H]1CN(c2c(F)cc(Br)cc2NC(=O)c2ccc(F)cc2C(F)(F)F)C[C@H](C)N1C |
| InChI | InChI=1S/C21H21BrF5N3O/c1-11-9-30(10-12(2)29(11)3)19-17(24)6-13(22)7-18(19)28-20(31)15-5-4-14(23)8-16(15)21(25,26)27/h4-8,11-12H,9-10H2,1-3H3,(H,28,31)/t11-,12-/m0/s1 |
| InChIKey | ZITRZJFVWXDGNU-RYUDHWBXSA-N |
| XLogP | 5.53 |
| TPSA | 35.58 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 506.31 |
| LogP ≤ 5 | 5.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156905317 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.